Advertisement

Index by author

September 01, 1986; Volume 238,Issue 3

A

  1. Acara, M A

    1. Thiazide diuretics inhibit chloride absorption by rabbit distal colon.
      P C Ferriola, M A Acara and M E Duffey
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 912-915;

  2. Adler, M W

    1. Autonomic mechanisms for morphine and amphetamine mydriasis in the rat.
      H Klemfuss and M W Adler
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 788-793;

  3. Albers, L J

    1. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
      E J Hess, L J Albers, H Le and I Creese
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 846-854;

  4. Aleem, A

    1. Opiate withdrawal-induced hyposensitivity to naloxone's effects on serum luteinizing hormone in the male rat.
      T J Cicero, A Aleem, E R Meyer, P F Schmoeker and B T Miller
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1063-1070;

  5. Allan, A M

    1. Anesthetic and convulsant barbiturates alter gamma-aminobutyric acid-stimulated chloride flux across brain membranes.
      A M Allan and R A Harris
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 763-768;

B

  1. Badr, M Z

    1. Mechanism of hepatotoxicity in periportal regions of the liver lobule due to allyl alcohol: studies on thiols and energy status.
      S A Belinsky, M Z Badr, F C Kauffman and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1132-1137;
    2. Mechanism of hepatotoxicity to periportal regions of the liver lobule due to allyl alcohol: role of oxygen and lipid peroxidation.
      M Z Badr, S A Belinsky, F C Kauffman and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1138-1142;

  2. Barrett, J E

    1. Behavioral studies with anxiolytic drugs. III. Antipunishment actions of buspirone in the pigeon do not involve benzodiazepine receptor mechanisms.
      J E Barrett, J M Witkin, R S Mansbach, P Skolnick and B A Weissman
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1009-1013;

  3. Belinsky, S A

    1. Mechanism of hepatotoxicity in periportal regions of the liver lobule due to allyl alcohol: studies on thiols and energy status.
      S A Belinsky, M Z Badr, F C Kauffman and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1132-1137;
    2. Mechanism of hepatotoxicity to periportal regions of the liver lobule due to allyl alcohol: role of oxygen and lipid peroxidation.
      M Z Badr, S A Belinsky, F C Kauffman and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1138-1142;

  4. Belis, J A

    1. Abnormalities of rat bladder contractility in streptozotocin-induced diabetes mellitus.
      P A Longhurst and J A Belis
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 773-777;

  5. Bevan, J A

    1. Alpha adrenoceptor antagonists selectively reduce thrombin-stimulated contraction in rabbit arteries.
      C J Garland and J A Bevan
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 947-953;

  6. Billings, R E

    1. Effects of nitrous oxide on macromolecular content and DNA synthesis in rat embryos.
      D K Hansen and R E Billings
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 985-989;

  7. Brady, J V

    1. Comparison of opioid self-injection and disruption of schedule-controlled performance in the baboon.
      S E Lukas, J V Brady and R R Griffiths
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 924-931;

  8. Breese, G R

    1. GABAergic modulation of inferior colliculus excitability: role in the ethanol withdrawal audiogenic seizures. Erratum and additional information.
      G D Frye, T J McCown, G R Breese and S L Peterson
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1143;

  9. Bruckert, J W

    1. Development of adrenergic and nonadrenergic pressor mechanisms in rats sympathectomized from birth.
      E Mills, J W Bruckert and P G Smith
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1014-1020;

  10. Buchan, P

    1. Corticotropin-releasing factor inhibits neurogenic plasma extravasation in the rat paw.
      E T Wei, J G Kiang, P Buchan and T W Smith
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 783-787;

  11. Bunney, B S

    1. Induction of depolarization block in midbrain dopamine neurons by repeated administration of haloperidol: analysis using in vivo intracellular recording.
      A A Grace and B S Bunney
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1092-1100;

C

  1. Carpenter, C L

    1. Depolarization-dependent binding of the calcium channel antagonist, (+)-[3H]PN200-110, to intact cultured PC12 cells.
      D A Greenberg, C L Carpenter and R O Messing
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1021-1027;

  2. Carpenter, R

    1. Effect of nitrendipine, diltiazem, trifluoperazine and pimozide on serotonin2 (5-HT2) receptor activation in the rat uterus and jugular vein.
      M L Cohen, R Carpenter, K Schenck, L Wittenauer and N Mason
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 860-867;

  3. Cicero, T J

    1. Opiate withdrawal-induced hyposensitivity to naloxone's effects on serum luteinizing hormone in the male rat.
      T J Cicero, A Aleem, E R Meyer, P F Schmoeker and B T Miller
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1063-1070;

  4. Cioffi, C L

    1. Short-term desensitization of muscarinic cholinergic receptors in mouse neuroblastoma cells: selective loss of agonist low-affinity and pirenzepine high-affinity binding sites.
      C L Cioffi and E E el-Fakahany
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 916-923;

  5. Cohen, M L

    1. Opioid agonist activity of ICI 174864 and its carboxypeptidase degradation product, LY281217.
      M L Cohen, R T Shuman, J J Osborne and P D Gesellchen
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 769-772;
    2. Effect of nitrendipine, diltiazem, trifluoperazine and pimozide on serotonin2 (5-HT2) receptor activation in the rat uterus and jugular vein.
      M L Cohen, R Carpenter, K Schenck, L Wittenauer and N Mason
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 860-867;

  6. Collins, A C

    1. Differential effects of central nervous system depressants in long-sleep and short-sleep mice.
      R J Marley, L L Miner, J M Wehner and A C Collins
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1028-1033;

  7. Contreras, P C

    1. Metaphit, an acylating ligand for phencyclidine receptors: characterization of in vivo actions in the rat.
      P C Contreras, S Johnson, R Freedman, B Hoffer, K Olsen, M F Rafferty, R A Lessor, K C Rice, A E Jacobson and T L O'Donohue
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1101-1107;

  8. Costa, M

    1. Effects of cholinergic blockade, adrenergic blockade and sympathetic denervation on gastrointestinal myoelectric activity in guinea pig.
      J J Galligan, J B Furness and M Costa
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1114-1125;

  9. Creese, I

    1. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
      E J Hess, L J Albers, H Le and I Creese
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 846-854;

D

  1. Donlon, M A

    1. Organophosphate-induced histamine release from mast cells.
      H H Newball, M A Donlon, L R Procell, E A Helgeson and D R Franz
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 839-845;

  2. Drazen, J M

    1. Effects of milrinone on contractile responses of guinea pig trachea, lung parenchyma and pulmonary artery.
      T H Rossing and J M Drazen
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 874-879;

  3. Duckles, S P

    1. Evidence against serotonin as a vasoconstrictor neurotransmitter in the rabbit basilar artery.
      B Levitt and S P Duckles
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 880-885;

  4. Duffey, M E

    1. Thiazide diuretics inhibit chloride absorption by rabbit distal colon.
      P C Ferriola, M A Acara and M E Duffey
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 912-915;

  5. Duffy, P

    1. Neuromedin N mimics the actions of neurotensin in the ventral tegmental area but not in the nucleus accumbens.
      P W Kalivas, R Richardson-Carlson and P Duffy
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1126-1131;

  6. Duggan, D E

    1. Possible mechanisms for reduced plasma clearance of diflunisal in rat experimental renal failure.
      J H Lin, E H Ulm and D E Duggan
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 978-984;

  7. Dunham, E W

    1. Hypotensive and renal vasodilator effects of carbocyclic adenosine (aristeromycin) in anesthetized spontaneously hypertensive rats.
      E W Dunham and R Vince
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 954-959;

E

  1. Ehrhard, P

    1. o-Isothiocyanate dihydropyridine (oNCS-DHP), a long-acting, reversible inhibitor of the Ca++ channel.
      R Kozlowski, P Ehrhard, W Fischli, W Osterrieder and M Holck
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1084-1091;

  2. el-Fakahany, E E

    1. Short-term desensitization of muscarinic cholinergic receptors in mouse neuroblastoma cells: selective loss of agonist low-affinity and pirenzepine high-affinity binding sites.
      C L Cioffi and E E el-Fakahany
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 916-923;

F

  1. Fallon, M

    1. In vivo and in vitro effects of WR-2721 in experimental hypercalcemia in the rat.
      J Weiss, S T Walker, M Fallon and S Goldfarb
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 969-973;

  2. Fang, F G

    1. Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates.
      F G Fang, H L Fields and N M Lee
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1039-1044;

  3. Ferriola, P C

    1. Thiazide diuretics inhibit chloride absorption by rabbit distal colon.
      P C Ferriola, M A Acara and M E Duffey
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 912-915;

  4. Field, E

    1. Tolerance to the luteinizing hormone and prolactin suppressive effects of delta-9-tetrahydrocannabinol develops during chronic prepubertal treatment of female rats.
      E Field and L Tyrey
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1034-1038;

  5. Fields, H L

    1. Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates.
      F G Fang, H L Fields and N M Lee
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1039-1044;

  6. Fischli, W

    1. o-Isothiocyanate dihydropyridine (oNCS-DHP), a long-acting, reversible inhibitor of the Ca++ channel.
      R Kozlowski, P Ehrhard, W Fischli, W Osterrieder and M Holck
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1084-1091;

  7. Franz, D R

    1. Organophosphate-induced histamine release from mast cells.
      H H Newball, M A Donlon, L R Procell, E A Helgeson and D R Franz
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 839-845;

  8. Freedman, R

    1. Metaphit, an acylating ligand for phencyclidine receptors: characterization of in vivo actions in the rat.
      P C Contreras, S Johnson, R Freedman, B Hoffer, K Olsen, M F Rafferty, R A Lessor, K C Rice, A E Jacobson and T L O'Donohue
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1101-1107;

  9. Frye, G D

    1. GABAergic modulation of inferior colliculus excitability: role in the ethanol withdrawal audiogenic seizures. Erratum and additional information.
      G D Frye, T J McCown, G R Breese and S L Peterson
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1143;

  10. Furness, J B

    1. Effects of cholinergic blockade, adrenergic blockade and sympathetic denervation on gastrointestinal myoelectric activity in guinea pig.
      J J Galligan, J B Furness and M Costa
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1114-1125;

G

  1. Galligan, J J

    1. Effects of cholinergic blockade, adrenergic blockade and sympathetic denervation on gastrointestinal myoelectric activity in guinea pig.
      J J Galligan, J B Furness and M Costa
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1114-1125;

  2. Garland, C J

    1. Alpha adrenoceptor antagonists selectively reduce thrombin-stimulated contraction in rabbit arteries.
      C J Garland and J A Bevan
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 947-953;

  3. Gesellchen, P D

    1. Opioid agonist activity of ICI 174864 and its carboxypeptidase degradation product, LY281217.
      M L Cohen, R T Shuman, J J Osborne and P D Gesellchen
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 769-772;

  4. Gibb, J W

    1. Roles of D1 and D2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems.
      P K Sonsalla, J W Gibb and G R Hanson
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 932-937;

  5. Gilbeau, P M

    1. Dynorphin effects on plasma concentrations of anterior pituitary hormones in the nonhuman primate.
      P M Gilbeau, Y Hosobuchi and N M Lee
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 974-977;

  6. Goldfarb, S

    1. In vivo and in vitro effects of WR-2721 in experimental hypercalcemia in the rat.
      J Weiss, S T Walker, M Fallon and S Goldfarb
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 969-973;

  7. Grace, A A

    1. Induction of depolarization block in midbrain dopamine neurons by repeated administration of haloperidol: analysis using in vivo intracellular recording.
      A A Grace and B S Bunney
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1092-1100;

  8. Greenberg, D A

    1. Depolarization-dependent binding of the calcium channel antagonist, (+)-[3H]PN200-110, to intact cultured PC12 cells.
      D A Greenberg, C L Carpenter and R O Messing
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1021-1027;

  9. Griffiths, R R

    1. Comparison of opioid self-injection and disruption of schedule-controlled performance in the baboon.
      S E Lukas, J V Brady and R R Griffiths
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 924-931;

  10. Grover, G J

    1. Beta adrenoceptor control of the microvascular reserve in rabbit myocardium.
      G J Grover, M A Tierney and H R Weiss
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 868-873;

  11. Gruetter, C A

    1. Comparison of endothelium-dependent relaxation in bovine intrapulmonary artery and vein by acetylcholine and A23187.
      C A Gruetter and S M Lemke
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1055-1062;

H

  1. Haertzen, C A

    1. Human psychopharmacology of ketocyclazocine as compared with cyclazocine, morphine and placebo.
      K M Kumor, C A Haertzen, R E Johnson, T Kocher and D Jasinski
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 960-968;

  2. Hall, G E

    1. Bone resorption induced by parathyroid hormone and dibutyryl cyclic AMP: role of carbonic anhydrase.
      G E Hall and A D Kenny
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 778-782;

  3. Hansen, D K

    1. Effects of nitrous oxide on macromolecular content and DNA synthesis in rat embryos.
      D K Hansen and R E Billings
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 985-989;

  4. Hanson, G R

    1. Roles of D1 and D2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems.
      P K Sonsalla, J W Gibb and G R Hanson
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 932-937;

  5. Harris, R A

    1. Anesthetic and convulsant barbiturates alter gamma-aminobutyric acid-stimulated chloride flux across brain membranes.
      A M Allan and R A Harris
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 763-768;

  6. Harrison, J H

    1. Role of aniline metabolites in aniline-induced hemolytic anemia.
      J H Harrison and D J Jollow
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1045-1054;

  7. Helgeson, E A

    1. Organophosphate-induced histamine release from mast cells.
      H H Newball, M A Donlon, L R Procell, E A Helgeson and D R Franz
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 839-845;

  8. Hess, E J

    1. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
      E J Hess, L J Albers, H Le and I Creese
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 846-854;

  9. Hoffer, B

    1. Metaphit, an acylating ligand for phencyclidine receptors: characterization of in vivo actions in the rat.
      P C Contreras, S Johnson, R Freedman, B Hoffer, K Olsen, M F Rafferty, R A Lessor, K C Rice, A E Jacobson and T L O'Donohue
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1101-1107;

  10. Holck, M

    1. o-Isothiocyanate dihydropyridine (oNCS-DHP), a long-acting, reversible inhibitor of the Ca++ channel.
      R Kozlowski, P Ehrhard, W Fischli, W Osterrieder and M Holck
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1084-1091;

  11. Holtzman, S G

    1. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
      K W Locke and S G Holtzman
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 990-996;
    2. Behavioral effects of opioid peptides selective for mu or delta receptors. II. Locomotor activity in nondependent and morphine-dependent rats.
      K W Locke and S G Holtzman
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 997-1003;

  12. Hori, R

    1. Mechanisms of gentamicin transport in kidney epithelial cell line (LLC-PK1).
      H Saito, K Inui and R Hori
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1071-1076;

  13. Hosobuchi, Y

    1. Dynorphin effects on plasma concentrations of anterior pituitary hormones in the nonhuman primate.
      P M Gilbeau, Y Hosobuchi and N M Lee
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 974-977;

I

  1. Inui, K

    1. Mechanisms of gentamicin transport in kidney epithelial cell line (LLC-PK1).
      H Saito, K Inui and R Hori
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1071-1076;

J

  1. Jacobson, A E

    1. Metaphit, an acylating ligand for phencyclidine receptors: characterization of in vivo actions in the rat.
      P C Contreras, S Johnson, R Freedman, B Hoffer, K Olsen, M F Rafferty, R A Lessor, K C Rice, A E Jacobson and T L O'Donohue
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1101-1107;

  2. James, M O

    1. Differential induction of ethoxyresorufin-O-deethylase in tissues of the rat placenta.
      K T Shiverick, C Swanson, A S Salhab and M O James
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1108-1113;

  3. Jasinski, D

    1. Human psychopharmacology of ketocyclazocine as compared with cyclazocine, morphine and placebo.
      K M Kumor, C A Haertzen, R E Johnson, T Kocher and D Jasinski
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 960-968;

  4. Johnson, K M

    1. Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs.
      L D Snell and K M Johnson
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 938-946;

  5. Johnson, M D

    1. Downregulation of [3H]Ro5-4864 binding sites after exposure to peripheral-type benzodiazepines in vitro.
      M D Johnson, J K Wang, J I Morgan and S Spector
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 855-859;

  6. Johnson, R E

    1. Human psychopharmacology of ketocyclazocine as compared with cyclazocine, morphine and placebo.
      K M Kumor, C A Haertzen, R E Johnson, T Kocher and D Jasinski
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 960-968;

  7. Johnson, S

    1. Metaphit, an acylating ligand for phencyclidine receptors: characterization of in vivo actions in the rat.
      P C Contreras, S Johnson, R Freedman, B Hoffer, K Olsen, M F Rafferty, R A Lessor, K C Rice, A E Jacobson and T L O'Donohue
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1101-1107;

  8. Jollow, D J

    1. Role of aniline metabolites in aniline-induced hemolytic anemia.
      J H Harrison and D J Jollow
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1045-1054;

K

  1. Kalivas, P W

    1. Neuromedin N mimics the actions of neurotensin in the ventral tegmental area but not in the nucleus accumbens.
      P W Kalivas, R Richardson-Carlson and P Duffy
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1126-1131;

  2. Kauffman, F C

    1. Mechanism of hepatotoxicity in periportal regions of the liver lobule due to allyl alcohol: studies on thiols and energy status.
      S A Belinsky, M Z Badr, F C Kauffman and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1132-1137;
    2. Mechanism of hepatotoxicity to periportal regions of the liver lobule due to allyl alcohol: role of oxygen and lipid peroxidation.
      M Z Badr, S A Belinsky, F C Kauffman and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1138-1142;

  3. Kenny, A D

    1. Bone resorption induced by parathyroid hormone and dibutyryl cyclic AMP: role of carbonic anhydrase.
      G E Hall and A D Kenny
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 778-782;

  4. Kiang, J G

    1. Corticotropin-releasing factor inhibits neurogenic plasma extravasation in the rat paw.
      E T Wei, J G Kiang, P Buchan and T W Smith
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 783-787;

  5. King, L W

    1. Cardiovascular actions and pharmacokinetics of desethyl-N-acetylprocainamide in the dog.
      J J Lertora and L W King
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 893-899;

  6. Klemfuss, H

    1. Autonomic mechanisms for morphine and amphetamine mydriasis in the rat.
      H Klemfuss and M W Adler
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 788-793;

  7. Kobayashi, M

    1. Cardiotoxic effects of maitotoxin, a principal toxin of seafood poisoning, on guinea pig and rat cardiac muscle.
      M Kobayashi, S Kondo, T Yasumoto and Y Ohizumi
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1077-1083;

  8. Kocher, T

    1. Human psychopharmacology of ketocyclazocine as compared with cyclazocine, morphine and placebo.
      K M Kumor, C A Haertzen, R E Johnson, T Kocher and D Jasinski
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 960-968;

  9. Kondo, S

    1. Cardiotoxic effects of maitotoxin, a principal toxin of seafood poisoning, on guinea pig and rat cardiac muscle.
      M Kobayashi, S Kondo, T Yasumoto and Y Ohizumi
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1077-1083;

  10. Kozlowski, R

    1. o-Isothiocyanate dihydropyridine (oNCS-DHP), a long-acting, reversible inhibitor of the Ca++ channel.
      R Kozlowski, P Ehrhard, W Fischli, W Osterrieder and M Holck
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1084-1091;

  11. Kraemer, F B

    1. Effects of ketoconazole on cholesterol synthesis.
      F B Kraemer and S D Spilman
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 905-911;

  12. Kumor, K M

    1. Human psychopharmacology of ketocyclazocine as compared with cyclazocine, morphine and placebo.
      K M Kumor, C A Haertzen, R E Johnson, T Kocher and D Jasinski
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 960-968;

L

  1. Le, H

    1. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
      E J Hess, L J Albers, H Le and I Creese
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 846-854;

  2. Lee, N M

    1. Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates.
      F G Fang, H L Fields and N M Lee
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1039-1044;
    2. Dynorphin effects on plasma concentrations of anterior pituitary hormones in the nonhuman primate.
      P M Gilbeau, Y Hosobuchi and N M Lee
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 974-977;

  3. Lemke, S M

    1. Comparison of endothelium-dependent relaxation in bovine intrapulmonary artery and vein by acetylcholine and A23187.
      C A Gruetter and S M Lemke
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1055-1062;

  4. Lertora, J J

    1. Cardiovascular actions and pharmacokinetics of desethyl-N-acetylprocainamide in the dog.
      J J Lertora and L W King
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 893-899;

  5. Lessor, R A

    1. Metaphit, an acylating ligand for phencyclidine receptors: characterization of in vivo actions in the rat.
      P C Contreras, S Johnson, R Freedman, B Hoffer, K Olsen, M F Rafferty, R A Lessor, K C Rice, A E Jacobson and T L O'Donohue
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1101-1107;

  6. Levitt, B

    1. Evidence against serotonin as a vasoconstrictor neurotransmitter in the rabbit basilar artery.
      B Levitt and S P Duckles
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 880-885;

  7. Liang, B T

    1. Beta adrenergic receptor subtypes in the atria: evidence for close coupling of beta-1 and beta-2 adrenergic receptors to adenylate cyclase.
      B T Liang and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 886-892;

  8. Lin, J H

    1. Possible mechanisms for reduced plasma clearance of diflunisal in rat experimental renal failure.
      J H Lin, E H Ulm and D E Duggan
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 978-984;

  9. Locke, K W

    1. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
      K W Locke and S G Holtzman
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 990-996;
    2. Behavioral effects of opioid peptides selective for mu or delta receptors. II. Locomotor activity in nondependent and morphine-dependent rats.
      K W Locke and S G Holtzman
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 997-1003;

  10. Longhurst, P A

    1. Abnormalities of rat bladder contractility in streptozotocin-induced diabetes mellitus.
      P A Longhurst and J A Belis
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 773-777;

  11. Lukas, S E

    1. Comparison of opioid self-injection and disruption of schedule-controlled performance in the baboon.
      S E Lukas, J V Brady and R R Griffiths
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 924-931;

M

  1. Mansbach, R S

    1. Behavioral studies with anxiolytic drugs. III. Antipunishment actions of buspirone in the pigeon do not involve benzodiazepine receptor mechanisms.
      J E Barrett, J M Witkin, R S Mansbach, P Skolnick and B A Weissman
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1009-1013;

  2. Marley, R J

    1. Differential effects of central nervous system depressants in long-sleep and short-sleep mice.
      R J Marley, L L Miner, J M Wehner and A C Collins
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1028-1033;

  3. Mason, N

    1. Effect of nitrendipine, diltiazem, trifluoperazine and pimozide on serotonin2 (5-HT2) receptor activation in the rat uterus and jugular vein.
      M L Cohen, R Carpenter, K Schenck, L Wittenauer and N Mason
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 860-867;

  4. Mayersohn, M

    1. Disposition kinetics of the monohydroxy metabolites of phencyclidine in the dog.
      J R Woodworth, M Mayersohn and S M Owens
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 900-904;

  5. McCown, T J

    1. GABAergic modulation of inferior colliculus excitability: role in the ethanol withdrawal audiogenic seizures. Erratum and additional information.
      G D Frye, T J McCown, G R Breese and S L Peterson
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1143;

  6. Messing, R O

    1. Depolarization-dependent binding of the calcium channel antagonist, (+)-[3H]PN200-110, to intact cultured PC12 cells.
      D A Greenberg, C L Carpenter and R O Messing
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1021-1027;

  7. Metz, S A

    1. p-Hydroxymercuribenzoic acid inhibits arachidonic acid esterification into two distinct pools and stimulates insulin release in intact rat islets.
      S A Metz
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 809-818;
    2. Putative roles for lysophospholipids as mediators and lipoxygenase-mediated metabolites of arachidonic acid as potentiators of stimulus-secretion coupling: dual mechanisms of p-hydroxymercuribenzoic acid-induced insulin release.
      S A Metz
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 819-832;

  8. Meyer, E R

    1. Opiate withdrawal-induced hyposensitivity to naloxone's effects on serum luteinizing hormone in the male rat.
      T J Cicero, A Aleem, E R Meyer, P F Schmoeker and B T Miller
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1063-1070;

  9. Miller, B T

    1. Opiate withdrawal-induced hyposensitivity to naloxone's effects on serum luteinizing hormone in the male rat.
      T J Cicero, A Aleem, E R Meyer, P F Schmoeker and B T Miller
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1063-1070;

  10. Mills, E

    1. Development of adrenergic and nonadrenergic pressor mechanisms in rats sympathectomized from birth.
      E Mills, J W Bruckert and P G Smith
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1014-1020;

  11. Miner, L L

    1. Differential effects of central nervous system depressants in long-sleep and short-sleep mice.
      R J Marley, L L Miner, J M Wehner and A C Collins
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1028-1033;

  12. Molinoff, P B

    1. Beta adrenergic receptor subtypes in the atria: evidence for close coupling of beta-1 and beta-2 adrenergic receptors to adenylate cyclase.
      B T Liang and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 886-892;

  13. Morgan, J I

    1. Downregulation of [3H]Ro5-4864 binding sites after exposure to peripheral-type benzodiazepines in vitro.
      M D Johnson, J K Wang, J I Morgan and S Spector
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 855-859;

  14. Murray, D L

    1. Vasoconstrictor threshold synergism and potentiation in the rabbit isolated thoracic aorta.
      G L Stupecky, D L Murray and R E Purdy
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 802-808;

N

  1. Newball, H H

    1. Organophosphate-induced histamine release from mast cells.
      H H Newball, M A Donlon, L R Procell, E A Helgeson and D R Franz
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 839-845;

O

  1. O'Donohue, T L

    1. Metaphit, an acylating ligand for phencyclidine receptors: characterization of in vivo actions in the rat.
      P C Contreras, S Johnson, R Freedman, B Hoffer, K Olsen, M F Rafferty, R A Lessor, K C Rice, A E Jacobson and T L O'Donohue
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1101-1107;

  2. Ohizumi, Y

    1. Cardiotoxic effects of maitotoxin, a principal toxin of seafood poisoning, on guinea pig and rat cardiac muscle.
      M Kobayashi, S Kondo, T Yasumoto and Y Ohizumi
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1077-1083;

  3. Okamoto, M

    1. Effect of dosing frequency on the development of physical dependence and tolerance to pentobarbital.
      M Okamoto, S Rao and J L Walewski
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1004-1008;

  4. Olsen, K

    1. Metaphit, an acylating ligand for phencyclidine receptors: characterization of in vivo actions in the rat.
      P C Contreras, S Johnson, R Freedman, B Hoffer, K Olsen, M F Rafferty, R A Lessor, K C Rice, A E Jacobson and T L O'Donohue
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1101-1107;

  5. Osborne, J J

    1. Opioid agonist activity of ICI 174864 and its carboxypeptidase degradation product, LY281217.
      M L Cohen, R T Shuman, J J Osborne and P D Gesellchen
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 769-772;

  6. Osterrieder, W

    1. o-Isothiocyanate dihydropyridine (oNCS-DHP), a long-acting, reversible inhibitor of the Ca++ channel.
      R Kozlowski, P Ehrhard, W Fischli, W Osterrieder and M Holck
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1084-1091;

  7. Owens, S M

    1. Disposition kinetics of the monohydroxy metabolites of phencyclidine in the dog.
      J R Woodworth, M Mayersohn and S M Owens
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 900-904;

P

  1. Peterson, S L

    1. GABAergic modulation of inferior colliculus excitability: role in the ethanol withdrawal audiogenic seizures. Erratum and additional information.
      G D Frye, T J McCown, G R Breese and S L Peterson
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1143;

  2. Procell, L R

    1. Organophosphate-induced histamine release from mast cells.
      H H Newball, M A Donlon, L R Procell, E A Helgeson and D R Franz
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 839-845;

  3. Purdy, R E

    1. Vasoconstrictor threshold synergism and potentiation in the rabbit isolated thoracic aorta.
      G L Stupecky, D L Murray and R E Purdy
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 802-808;

R

  1. Rafferty, M F

    1. Metaphit, an acylating ligand for phencyclidine receptors: characterization of in vivo actions in the rat.
      P C Contreras, S Johnson, R Freedman, B Hoffer, K Olsen, M F Rafferty, R A Lessor, K C Rice, A E Jacobson and T L O'Donohue
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1101-1107;

  2. Rao, S

    1. Effect of dosing frequency on the development of physical dependence and tolerance to pentobarbital.
      M Okamoto, S Rao and J L Walewski
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1004-1008;

  3. Rice, K C

    1. Metaphit, an acylating ligand for phencyclidine receptors: characterization of in vivo actions in the rat.
      P C Contreras, S Johnson, R Freedman, B Hoffer, K Olsen, M F Rafferty, R A Lessor, K C Rice, A E Jacobson and T L O'Donohue
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1101-1107;

  4. Richardson-Carlson, R

    1. Neuromedin N mimics the actions of neurotensin in the ventral tegmental area but not in the nucleus accumbens.
      P W Kalivas, R Richardson-Carlson and P Duffy
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1126-1131;

  5. Rosen, M R

    1. Frequency-dependent actions of phenytoin in adult and young canine Purkinje fibers.
      W Spinelli and M R Rosen
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 794-801;

  6. Rossing, T H

    1. Effects of milrinone on contractile responses of guinea pig trachea, lung parenchyma and pulmonary artery.
      T H Rossing and J M Drazen
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 874-879;

S

  1. Saito, H

    1. Mechanisms of gentamicin transport in kidney epithelial cell line (LLC-PK1).
      H Saito, K Inui and R Hori
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1071-1076;

  2. Salhab, A S

    1. Differential induction of ethoxyresorufin-O-deethylase in tissues of the rat placenta.
      K T Shiverick, C Swanson, A S Salhab and M O James
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1108-1113;

  3. Schenck, K

    1. Effect of nitrendipine, diltiazem, trifluoperazine and pimozide on serotonin2 (5-HT2) receptor activation in the rat uterus and jugular vein.
      M L Cohen, R Carpenter, K Schenck, L Wittenauer and N Mason
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 860-867;

  4. Schmoeker, P F

    1. Opiate withdrawal-induced hyposensitivity to naloxone's effects on serum luteinizing hormone in the male rat.
      T J Cicero, A Aleem, E R Meyer, P F Schmoeker and B T Miller
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1063-1070;

  5. Shiverick, K T

    1. Differential induction of ethoxyresorufin-O-deethylase in tissues of the rat placenta.
      K T Shiverick, C Swanson, A S Salhab and M O James
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1108-1113;

  6. Shuman, R T

    1. Opioid agonist activity of ICI 174864 and its carboxypeptidase degradation product, LY281217.
      M L Cohen, R T Shuman, J J Osborne and P D Gesellchen
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 769-772;

  7. Skolnick, P

    1. Behavioral studies with anxiolytic drugs. III. Antipunishment actions of buspirone in the pigeon do not involve benzodiazepine receptor mechanisms.
      J E Barrett, J M Witkin, R S Mansbach, P Skolnick and B A Weissman
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1009-1013;

  8. Smith, P G

    1. Development of adrenergic and nonadrenergic pressor mechanisms in rats sympathectomized from birth.
      E Mills, J W Bruckert and P G Smith
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1014-1020;

  9. Smith, T W

    1. Corticotropin-releasing factor inhibits neurogenic plasma extravasation in the rat paw.
      E T Wei, J G Kiang, P Buchan and T W Smith
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 783-787;

  10. Snell, L D

    1. Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs.
      L D Snell and K M Johnson
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 938-946;

  11. Sonsalla, P K

    1. Roles of D1 and D2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems.
      P K Sonsalla, J W Gibb and G R Hanson
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 932-937;

  12. Spector, S

    1. Downregulation of [3H]Ro5-4864 binding sites after exposure to peripheral-type benzodiazepines in vitro.
      M D Johnson, J K Wang, J I Morgan and S Spector
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 855-859;

  13. Spilman, S D

    1. Effects of ketoconazole on cholesterol synthesis.
      F B Kraemer and S D Spilman
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 905-911;

  14. Spinelli, W

    1. Frequency-dependent actions of phenytoin in adult and young canine Purkinje fibers.
      W Spinelli and M R Rosen
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 794-801;

  15. Stevens, C W

    1. Dynorphin A and related peptides administered intrathecally in the rat: a search for putative kappa opiate receptor activity.
      C W Stevens and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 833-838;

  16. Stupecky, G L

    1. Vasoconstrictor threshold synergism and potentiation in the rabbit isolated thoracic aorta.
      G L Stupecky, D L Murray and R E Purdy
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 802-808;

  17. Swanson, C

    1. Differential induction of ethoxyresorufin-O-deethylase in tissues of the rat placenta.
      K T Shiverick, C Swanson, A S Salhab and M O James
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1108-1113;

T

  1. Thurman, R G

    1. Mechanism of hepatotoxicity in periportal regions of the liver lobule due to allyl alcohol: studies on thiols and energy status.
      S A Belinsky, M Z Badr, F C Kauffman and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1132-1137;
    2. Mechanism of hepatotoxicity to periportal regions of the liver lobule due to allyl alcohol: role of oxygen and lipid peroxidation.
      M Z Badr, S A Belinsky, F C Kauffman and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1138-1142;

  2. Tierney, M A

    1. Beta adrenoceptor control of the microvascular reserve in rabbit myocardium.
      G J Grover, M A Tierney and H R Weiss
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 868-873;

  3. Tyrey, L

    1. Tolerance to the luteinizing hormone and prolactin suppressive effects of delta-9-tetrahydrocannabinol develops during chronic prepubertal treatment of female rats.
      E Field and L Tyrey
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1034-1038;

U

  1. Ulm, E H

    1. Possible mechanisms for reduced plasma clearance of diflunisal in rat experimental renal failure.
      J H Lin, E H Ulm and D E Duggan
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 978-984;

V

  1. Vince, R

    1. Hypotensive and renal vasodilator effects of carbocyclic adenosine (aristeromycin) in anesthetized spontaneously hypertensive rats.
      E W Dunham and R Vince
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 954-959;

W

  1. Walewski, J L

    1. Effect of dosing frequency on the development of physical dependence and tolerance to pentobarbital.
      M Okamoto, S Rao and J L Walewski
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1004-1008;

  2. Walker, S T

    1. In vivo and in vitro effects of WR-2721 in experimental hypercalcemia in the rat.
      J Weiss, S T Walker, M Fallon and S Goldfarb
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 969-973;

  3. Wang, J K

    1. Downregulation of [3H]Ro5-4864 binding sites after exposure to peripheral-type benzodiazepines in vitro.
      M D Johnson, J K Wang, J I Morgan and S Spector
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 855-859;

  4. Wehner, J M

    1. Differential effects of central nervous system depressants in long-sleep and short-sleep mice.
      R J Marley, L L Miner, J M Wehner and A C Collins
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1028-1033;

  5. Wei, E T

    1. Corticotropin-releasing factor inhibits neurogenic plasma extravasation in the rat paw.
      E T Wei, J G Kiang, P Buchan and T W Smith
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 783-787;

  6. Weiss, H R

    1. Beta adrenoceptor control of the microvascular reserve in rabbit myocardium.
      G J Grover, M A Tierney and H R Weiss
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 868-873;

  7. Weiss, J

    1. In vivo and in vitro effects of WR-2721 in experimental hypercalcemia in the rat.
      J Weiss, S T Walker, M Fallon and S Goldfarb
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 969-973;

  8. Weissman, B A

    1. Behavioral studies with anxiolytic drugs. III. Antipunishment actions of buspirone in the pigeon do not involve benzodiazepine receptor mechanisms.
      J E Barrett, J M Witkin, R S Mansbach, P Skolnick and B A Weissman
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1009-1013;

  9. Witkin, J M

    1. Behavioral studies with anxiolytic drugs. III. Antipunishment actions of buspirone in the pigeon do not involve benzodiazepine receptor mechanisms.
      J E Barrett, J M Witkin, R S Mansbach, P Skolnick and B A Weissman
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1009-1013;

  10. Wittenauer, L

    1. Effect of nitrendipine, diltiazem, trifluoperazine and pimozide on serotonin2 (5-HT2) receptor activation in the rat uterus and jugular vein.
      M L Cohen, R Carpenter, K Schenck, L Wittenauer and N Mason
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 860-867;

  11. Woodworth, J R

    1. Disposition kinetics of the monohydroxy metabolites of phencyclidine in the dog.
      J R Woodworth, M Mayersohn and S M Owens
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 900-904;

Y

  1. Yaksh, T L

    1. Dynorphin A and related peptides administered intrathecally in the rat: a search for putative kappa opiate receptor activity.
      C W Stevens and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 833-838;

  2. Yasumoto, T

    1. Cardiotoxic effects of maitotoxin, a principal toxin of seafood poisoning, on guinea pig and rat cardiac muscle.
      M Kobayashi, S Kondo, T Yasumoto and Y Ohizumi
      Journal of Pharmacology and Experimental Therapeutics September 1986, 238 (3) 1077-1083;
Back to top

In this issue